Sensulin Featured in Forbes by Reenita Das

Having Diabetes Is No Longer Going To Be A Life Sentence

"Another advance that will change the field is being developed by Sensulin and other major pharma companies like Eli Lilly–glucose-responsive, once-a-day insulin that could potentially replace basal and prandial insulin. While this insulin still would be taken once a day through the same insulin pens or other delivery devices, the release of insulin in the body would be controlled by blood glucose levels alone, controlling these levels far better than regular insulin delivery."

For the full article by Reenita Das